Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma

International Journal of Oncology

Volumn 43, Issue 5, 2013, Pages 1523-1530

  Kwon, Junhye ^a,b   Lee, Tae Sup ^c   Lee, Hae Won ^a   Kang, Moon Chul ^a   Yoon, Hyeon Joon ^a   Kim, Ji Hee ^a   Park, Jong Ho ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

Biodistribution; Esophageal squamous cell carcinoma; Integrin alpha 6; Tumorigenesis; Xenograft model

Indexed keywords

ALPHA6 INTEGRIN; BETA4 INTEGRIN; HETERODIMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CELL SURFACE; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CARCINOGENESIS; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTEGRIN ALPHA6; INTEGRIN BETA4; MICE; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84885082897     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2097     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Darling G: The role of lymphadenectomy in esophageal cancer. J Surg Oncol 99: 189-193, 2009.
3. Kranzfelder M, Schuster T, Geinitz H, Friess H and Buchler P: Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer. Br J Surg 98: 768-783, 2011.
4. Chiu PW, Chan AC, Leung SF, et al: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the chinese university research group for esophageal cancer (CURE). J Gastrointest Surg 9: 794-802, 2005.
5. Xu XH, Peng XH, Yu P, Xu XY, Cai EH, Guo P and Li K: Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials. Asian Pac J Cancer Prev 13: 103-110, 2012.
6. Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25, 1992.
7. Giancotti FG and Tarone G: Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19: 173-206, 2003.
8. Avraamides CJ, Garmy-Susini B and Varner JA: Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8: 604-617, 2008.
9. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138, 1999.
10. Hwang R and Varner J: The role of integrins in tumor angiogenesis. Hematol Oncol Clin North Am 18: 991-1006, 2004.
11. Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ and Imhof BA: High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 55: 901-906, 1995.
12. Mercurio AM and Rabinovitz I: Towards a mechanistic understanding of tumor invasion - lessons from the alpha6beta 4 integrin. Semin Cancer Biol 11: 129-141, 2001.
13. Mukhopadhyay R, Theriault RL and Price JE: Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 17: 325-332, 1999.
14. Wewer UM, Shaw LM, Albrechtsen R and Mercurio AM: The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am J Pathol 151: 1191-1198, 1997.
15. Hemler ME, Crouse C and Sonnenberg A: Association of the VLA alpha 6 subunit with a novel protein. A possible alternative to the common VLA beta 1 subunit on certain cell lines. J Biol Chem 264: 6529-6535, 1989.
16. Hu YC, Lam KY, Law S, Wong J and Srivastava G: Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC. Clin Cancer Res 7: 3519-3525, 2001.
17. Kwon YJ, Lee SJ, Koh JS, Kim SH, Kim YJ and Park JH: Expression patterns of aurora kinase B, heat shock protein 47, and periostin in esophageal squamous cell carcinoma. Oncol Res 18: 141-151, 2009.
18. Lathia JD, Gallagher J, Heddleston JM, et al: Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432, 2010.
19. Tew WP, Kelsen DP and Ilson DH: Targeted therapies for esophageal cancer. Oncologist 10: 590-601, 2005.
20. Vanhoefer U, Tewes M, Rojo F, et al: Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor. J Clin Oncol 22: 175-184, 2004.
21. Capdevila J, Elez E, Macarulla T, Ramos FJ, Ruiz-Echarri M and Tabernero J: Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat Rev 35: 354-363, 2009.
22. Cruz-Monserrate Z and O'Connor KL: Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1 upregulation, and subsequent rac activation. Neoplasia 10: 408-417, 2008.
23. Yang XH, Richardson AL, Torres-Arzayus MI, et al: CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res 68: 3204-3213, 2008.
24. Chung J and Mercurio AM: Contributions of the alpha6 integrins to breast carcinoma survival and progression. Mol Cells 17: 203-209, 2004.
25. Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C and Purushotham AD: Alpha-6 integrin is necessary for the tumouri-genicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 122: 298-304, 2008.
26. Su JM, Gui L, Zhou YP and Zha XL: Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance. World J Gastroenterol 8: 613-618, 2002.
27. Varner JA, Emerson DA and Juliano RL: Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 6: 725-740, 1995.
28. Beaulieu JF: Integrin alpha6beta4 in colorectal cancer. World J Gastrointest Pathophysiol 1: 3-11, 2010.
29. Noh TW, Soung YH, Kim HI, Gil HJ, Kim JM, Lee EJ and Chung J: Effect of {beta}4 integrin knockdown by RNA interference in anaplastic thyroid carcinoma. Anticancer Res 30: 4485-4492, 2010.
30. Bon G, Folgiero V, Di Carlo S, Sacchi A and Falcioni R: Involvement of alpha6beta4 integrin in the mechanisms that regulate breast cancer progression. Breast Cancer Res 9: 203, 2007.
31. Lu X, Lu D, Scully M and Kakkar V: The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. Perspect Medicin Chem 2: 57-73, 2008.